Enwei Pharmaceutical Co., Ltd. (SHE:301331)
China · Delayed Price · Currency is CNY 26.10
-0.82 (-3.05%)
Apr 9, 2026, 4:00 PM EDT
8.75% (1Y)
| Market Cap | 2.64B +9.0% |
| Revenue (ttm) | 888.64M +14.6% |
| Net Income | 52.06M +47.1% |
| EPS | 0.52 +49.9% |
| Shares Out | 101.08M |
| PE Ratio | 50.08 |
| Forward PE | n/a |
| Dividend | 0.35 (1.30%) |
| Ex-Dividend Date | Jan 8, 2026 |
| Volume | 1,049,700 |
| Average Volume | 1,127,902 |
| Open | 26.80 |
| Previous Close | 26.92 |
| Day's Range | 26.01 - 27.03 |
| 52-Week Range | 21.64 - 39.66 |
| Beta | 0.65 |
| RSI | 45.50 |
| Earnings Date | Apr 27, 2026 |